Athyrium Opportunities Fund III1
| Company | Description | Initial Investment Date |
|---|---|---|
| CareMax | Multi-Specialty Provider Group | February 2017 |
| Alvogen | Specialty Generics | April 2017 |
| Teladoc | Telemedicine Platform | July 2017 |
| OB Hospitalist Group | OB Hospitalist Services | August 2017 |
| DuPage Medical Group | Multi-Specialty Physician Group | August 2017 |
| Biora Therapeutics, Inc. | Prenatal Women's Health Genetics and Gastrointestinal / Inflammatory Bowel Disease Precision Medicine | October 2017 |
| Societal CDMO | Post-Operative Pain / Contract Development and Manufacturing Organization | November 2017 |
| PharMerica | Institutional and Specialty Pharmacy Services Provider | December 2017 |
| Centinel Spine | Spine Total Disc Replacement and Integrated Interbody Systems | December 2017 |
| OptiNose | XHANCE / Exhalation Delivery Systems (EDS) platform | December 2017 |
| Veloxis | Envarsus XR / MeltDose Technology | February 2018 |
| Biom'Up | HEMOBLAST Bellows / Hemostatic Products | February 2018 |
| Aqua Dermatology | Dermatology Provider Group | May 2018 |
| VIVUS, Inc. | Pancreaze and Qsymia | June 2018 |
| TESARO, Inc. | Zejula / Oncology | June 2018 |
| Sound Inpatient Physicians, Inc. | Hospitalist Services | June 2018 |
| Agendia NV | Breast Cancer Diagnostics | July 2018 |
| Amryt Pharma | Orphan Pharmaceuticals | July 2018 |
| naviHealth, Inc. | Post-Acute Care Management | August 2018 |
| Kala Pharmaceuticals, Inc. | INVELTYS / Ophthalmic Pharmaceuticals | October 2018 |
| Dermira, Inc. | QBREXZA / Dermatology | December 2018 |
| Portola Pharmaceuticals, Inc. | Hematology Pharmaceuticals | February 2019 |
| Secura Bio | FARYDAK / Oncology | March 2019 |
| Longevity Health Founders LLC (Longevity Health Plan) | Institutional Special Needs Plan | March 2019 |
| ArisGlobal | HCIT | July 2019 |
| BW NHHC HoldCo Inc. (Elara Caring) | Home Health Services Platform | October 2019 |
| Upstream Rehabilitation | Physical Therapy Services Provider | October 2019 |
| InnovaCare Health | Integrated Payor and Provider Organization | December 2019 |
| Clario | HCIT | February 2020 |
| Leon Health Systems, LLC | Integrated Delivery System | October 2020 |
| BioCryst Pharmaceuticals, Inc. | ORLADEYO / rare disease | December 2020 |
1. This table lists all investments made by the Athyrium Opportunities Fund III.